相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer
A. Blythe Ryerson et al.
CANCER (2016)
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
Karen T. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems
Po-Hong Liu et al.
JOURNAL OF HEPATOLOGY (2016)
Preliminary Outcome of Microwave Ablation of Hepatocellular Carcinoma: Breaking the 3-cm Barrier?
Somrach Thamtorawat et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma
Pierce K. H. Chow et al.
LIVER CANCER (2016)
A systematic review of geographical variation in access to chemotherapy
Charlotte Chamberlain et al.
BMC CANCER (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort
Xavier Adhoute et al.
JOURNAL OF HEPATOLOGY (2015)
2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma
Joong-Won Park et al.
KOREAN JOURNAL OF RADIOLOGY (2015)
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2015)
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong-Won Park et al.
LIVER INTERNATIONAL (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Hong Kong Consensus Recommendations on the Management of Hepatocellular Carcinoma
Ronnie Tung-Ping Poon et al.
LIVER CANCER (2015)
Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe
M. Kudo
LIVER CANCER (2015)
Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)
Chiun Hsu et al.
LIVER CANCER (2015)
Surveillance, Diagnosis, Treatment, and Outcome of Liver Cancer in Japan
Masatoshi Kudo
LIVER CANCER (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
SALL4 Immunoreactivity Predicts Prognosis in Western Hepatocellular Carcinoma Patients but Is a Rare Event A Study of 236 Cases
Ta-Chiang Liu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma
Jian-hong Zhong et al.
ANNALS OF SURGERY (2014)
Epidemiology and Survival of Hepatocellular Carcinoma in the Central Region of Thailand
Krittapong Somboon et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
International comparison of the factors influencing reimbursement of targeted anti-cancer drugs
Carol Sunghye Lim et al.
BMC HEALTH SERVICES RESEARCH (2014)
The Clinical Management of Hepatocellular Carcinoma in the United States, Europe, and Asia A Comprehensive and Evidence-Based Comparison and Review
Zhi Ven Fong et al.
CANCER (2014)
Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
Thomas Yau et al.
GASTROENTEROLOGY (2014)
Epidemiology of Hepatocellular Carcinoma in the United States: Where Are We? Where Do We Go?
Hashem B. El-Serag et al.
HEPATOLOGY (2014)
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib The EVOLVE-1 Randomized Clinical Trial
Andrew X. Zhu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
AN INTERNATIONAL COLLABORATIVE STUDY ASSESSING THE ROLE OF AETIOLOGY AND STAGE IN SURVIVAL IN HCC - IMPLICATIONS FOR SCREENING
P. Johnson et al.
JOURNAL OF HEPATOLOGY (2014)
Comparison of Characteristics and Transarterial Chemoembolization Outcomes in Patients with Unresectable Hepatocellular Carcinoma and Different Viral Etiologies
Bang-Bin Chen et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2014)
Radiation Therapy for Liver Tumors: Ready for Inclusion in Guidelines?
Shyam K. Tanguturi et al.
ONCOLOGIST (2014)
Prognosis of Unresectable Hepatocellular Carcinoma: Comparison of Seven Staging Systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese Cohort
Jin-feng Zhang et al.
PLOS ONE (2014)
Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort
Dong Hyun Sinn et al.
PLOS ONE (2014)
Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma
Su-xia Han et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group
Guido Torzilli et al.
ANNALS OF SURGERY (2013)
Epidemiology and Survival of Hepatocellular Carcinoma in North-east Peninsular Malaysia
Bachok Norsa'adah et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Reduced Aflatoxin Exposure Presages Decline in Liver Cancer Mortality in an Endemic Region of China
Jian-Guo Chen et al.
CANCER PREVENTION RESEARCH (2013)
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
Zhengyan Kan et al.
GENOME RESEARCH (2013)
Yttrium 90 Radioembolization for the Treatment of Hepatocellular Carcinoma: Biological Lessons, Current Challenges, and Clinical Perspectives
Riad Salem et al.
HEPATOLOGY (2013)
Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan
Chun-Ju Chiang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Epidemiology of Hepatocellular Carcinoma Consider the Population
Sahil Mittal et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
Shukui Qin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
Josep M. Llovet et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
Ann-Lii Cheng et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
NAFLD in Asia-as common and important as in the West
Geoffrey C. Farrell et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
National Antiviral Treatment Program and the Incidence of Hepatocellular Carcinoma and Associated Mortality in Taiwan
Chia-Hsuin Chang et al.
MEDICAL CARE (2013)
Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma
Kol Jia Yong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool
Song Ling Poon et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma
Toshimi Kaido et al.
SURGERY (2013)
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
Jean Charles Nault et al.
NATURE COMMUNICATIONS (2013)
Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma
Yusuke Kawamura et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Comparison of Surgical Resection and Transarterial Chemoembolization for Hepatocellular Carcinoma beyond the Milan Criteria: A Propensity Score Analysis
Chia-Yang Hsu et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis
Yan Liu et al.
EUROPEAN JOURNAL OF CANCER (2012)
Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences
Jennifer Ng et al.
HEPATITIS MONTHLY (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2012)
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cecile Guichard et al.
NATURE GENETICS (2012)
Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors
Giuliana Amaddeo et al.
ONCOIMMUNOLOGY (2012)
Liver Transplantation for Advanced Hepatocellular Carcinoma Using Poor Tumor Differentiation on Biopsy as an Exclusion Criterion
Derek DuBay et al.
ANNALS OF SURGERY (2011)
Relative Etiological Role of Prior Hepatitis B Virus Infection and Nonalcoholic Fatty Liver Disease in the Development of Non-B Non-C Hepatocellular Carcinoma in a Hepatitis B-Endemic Area
Eun Ju Cho et al.
DIGESTION (2011)
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
Masatoshi Kudo et al.
EUROPEAN JOURNAL OF CANCER (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Total Numbers of Undiagnosed Carriers of Hepatitis C and B Viruses in Japan Estimated by Age- and Area-Specific Prevalence on the National Scale
Junko Tanaka et al.
INTERVIROLOGY (2011)
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
Meng Li et al.
NATURE GENETICS (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia
Kwang-Hyub Han et al.
ONCOLOGY (2011)
Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus-Related Cirrhosis
Ashwani K. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)
Shigeki Arii et al.
HEPATOLOGY RESEARCH (2010)
Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma A Randomized Trial
Ghassan K. Abou-Alfa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?
Fidel-David Huitzil-Melendez et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The 2008 Okuda lecture: Management of hepatocellular carcinoma: From surveillance to molecular targeted therapy
Masatoshi Kudo
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: Evidence from an updated meta-analysis
Bin Wang et al.
JOURNAL OF HEPATOLOGY (2010)
Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients
Chien-Hung Chen et al.
EUROPEAN JOURNAL OF CANCER (2009)
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Sean F. Altekruse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Epidemiology of hepatocellular carcinoma in Japan
Takeji Umemura et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Hepatocellular carcinoma in the Asia pacific region
Man-Fung Yuen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Liver transplantation for hepatocellular carcinoma
Vincenzo Mazzaferro et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Yun Ku Cho et al.
CANCER (2008)
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
Takeaki Ishizawa et al.
GASTROENTEROLOGY (2008)
Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry
Elizabeth M. Lehman et al.
HEPATOLOGY RESEARCH (2008)
Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI
Wenping Lu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Epidemiology of Hepatocellular Carcinoma in Japan and Korea
Soo Ryang Kim et al.
ONCOLOGY (2008)
Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
Asmaa Ibrahim Gomaa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma
Bruno Daniele et al.
HEPATOLOGY RESEARCH (2007)
Hepatocellular carcinoma: Trends of incidence and survival in Europe and the United States at the end of the 20th century
Riccardo Capocaccia et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
The burden of overweight and obesity in the Asia-Pacific region
Crystal Man Ying Lee et al.
OBESITY REVIEWS (2007)
Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma
Yo Sasaki et al.
ANNALS OF SURGERY (2006)
Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization
Christos S. Georgiades et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2006)
Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy
A Nanashima et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Genetics of hepatocellular tumors
P. Laurent-Puig et al.
ONCOGENE (2006)
A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma
W Yeo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients
G Varotti et al.
EJSO (2005)
Report of the 16th follow-up survey of primary liver cancer
I Ikai et al.
HEPATOLOGY RESEARCH (2005)
Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery
YH Huang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort
JA Marrero et al.
HEPATOLOGY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing nonsurgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre
A Grieco et al.
GUT (2005)
Randomized controlled trial of screening for hepatocellular carcinoma
BH Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000 - Analysis of 1365 patients in a single institution in Japan
H Toyoda et al.
CANCER (2004)
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?
U Cillo et al.
JOURNAL OF HEPATOLOGY (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)
M Kudo et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the Liver Italian Program staging system - A study based on 926 patients
TWT Leung et al.
CANCER (2002)
Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy
TWT Leung et al.
CANCER (2002)
Vaccination against hepatitis B: Current challenges for Asian countries and future directions
A Safary et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
分享论文
